Gait Assessment in Chronic Inflammatory Demyelinating Polyradiculoneuropathy
Llaurado, Arnau (Universitat Autònoma de Barcelona. Departament de Medicina)
Quintana, Manuel (Vall d'Hebron Institut de Recerca (VHIR))
Gratacòs-Viñola, Margarida (Vall d'Hebron Institut de Recerca (VHIR))
Vidal-Taboada, Jose Manuel (Vall d'Hebron Institut de Recerca (VHIR))
Restrepo, Juan Luis (Vall d'Hebron Institut de Recerca (VHIR))
Alemañ, José (Vall d'Hebron Institut de Recerca (VHIR))
López-Diego, Verónica (Vall d'Hebron Institut de Recerca (VHIR))
Salvadó, Maria (Vall d'Hebron Institut de Recerca (VHIR))
Sánchez-Tejerina, Daniel (Vall d'Hebron Institut de Recerca (VHIR))
Sotoca Fernández, Javier (Vall d'Hebron Institut de Recerca (VHIR))
Raguer, Nuria (Vall d'Hebron Institut de Recerca (VHIR))
Juntas Morales, Raúl (Vall d'Hebron Institut de Recerca (VHIR))

Data:	2024
Resum:	Background and Aims. Gait impairment is a common manifestation of chronic inflammatory demyelinating polyradiculoneuropathy (CIDP). However, clinicians lack an effective monitoring tool, as no gait test has been validated for CIDP. The aim of this study was to determine the usefulness of three tests in monitoring the clinical course of patients with CIDP: Timed Up and Go (TUG), 10-Meter Walk Test (10MWT), and 30-Second Chair Stand (30SCS). Methods. This is a prospective, single-center observational study. We included newly diagnosed CIDP patients starting treatment or relapsed CIDP patients requiring new treatment. We monitored the clinical course using CIDP-validated clinical scales and correlated changes in clinical status with the results of the gait tests. A ROC curve was developed, and we chose the cut-off point on each scale with the best specificity and sensitivity to detect change in clinical status. Results. A total of 20 patients have been recruited. The 3 tests show a statistical correlation with objective clinical improvement. In patients who have showed clinical improvement during the follow-up examination, a mean reduction of 4. 8 seconds in TUG and 2. 6 in 10MWT and a gain of 3 repetitions in 30SCS have been observed. The optimal cut-off points for each test were TUG≤1 seconds, 10MWT≤1 seconds, and 30SCS≥1 repetition. The TUG test has the highest sensitivity (82. 6%), and the 30SCS test has the highest specificity (100%) for detecting clinical improvement. Conclusions. The study found that the TUG and 30SCS tests could become effective tools for monitoring treatment response in CIDP patients.
Drets:	Aquest document està subjecte a una llicència d'ús Creative Commons. Es permet la reproducció total o parcial, la distribució, la comunicació pública de l'obra i la creació d'obres derivades, fins i tot amb finalitats comercials, sempre i quan es reconegui l'autoria de l'obra original.
Llengua:	Anglès
Document:	Article ; recerca ; Versió publicada
Publicat a:	Acta Neurologica Scandinavica, Vol. 2024 (2024) , ISSN 1600-0404

DOI: 10.1155/2024/7037704

5 p, 676.1 KB

El registre apareix a les col·leccions:
Articles > Articles de recerca
Articles > Articles publicats